BRCA1 and breast carcinoma: Rutin, identified via computational modeling, exhibits a strong binding affinity to BRCA-1 (breast cancer gene-1) [68], while MO-AuNPs demonstrate potent anticancer activity with an IC50 value of 67.92 μg/mL [180].